Publisher： Bentham Science Publishers
E-ISSN： 2212-389x|4|2|122-129
ISSN： 1574-3624
Source： Current Signal Transduction Therapy, Vol.4, Iss.2, 2009-05, pp. : 122-129
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
FOXP3 suppresses breast cancer metastasis through downregulation of CD44
INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. :
Access to resources
Recommend
The Proteasome, a New Target for Cancer Therapy
Oncology Research and Treatment, Vol. 25, Iss. 6, 2003-01 ,pp. :
The mu opioid receptor: A new target for cancer therapy?
CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. :
Imaging of TKI–Target Interactions for Personalized Cancer Therapy
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. :